SecBot SecBot
SC 13G ·Filed Oct 28, 2026

CMPS

COMPASS Pathways plc
NEUTRAL
Impact 4/10
Horizonweeks Processed1d 16h ago SEC0002053305-26-000008
Passive investor 5%+ stake
Actionable Insight • Neutral

A new 5.9% passive stake from a German investment firm adds a notable institutional holder. Monitor for any future amendments that could indicate a shift to active engagement or a 13D conversion, though the filing explicitly certifies passive intent.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled: T+1d
CMPS ▼ -0.73% at T+1d
NEUTRAL call -0.73% · α vs SPY -0.35% · entry $12.28 → $12.19
Next anchor: T+5d in 5d
Entry = T+0 close
Oct 28, 2026
via day close
T+1d
-0.73%
call -0.73% · α -0.35%
$12.19
settled 19h ago
T+5d
Pending
in 5d
T+20d
Pending
in 26d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

BIT Capital GmbH, a German investment firm, filed a new Schedule 13G disclosing a 5.9% passive stake in COMPASS Pathways plc as of September 30, 2026. This is a new 5%+ disclosure with no prior filings by this entity, indicating a significant new position in the company.

Key Financial Metrics

Stake
5.9%
Investor
BIT Capital GmbH

Key Facts

  • BIT Capital GmbH filed a new Schedule 13G on October 28, 2026, disclosing beneficial ownership of 8,148,280 American Depositary Shares (ADSs).
  • The stake represents 5.9% of COMPASS Pathways' outstanding ordinary shares, based on 138,476,822 shares outstanding as of July 30, 2026.
  • This is a new position; BIT Capital GmbH has no prior Schedule 13G or 13D filings for COMPASS Pathways.
  • The filing certifies passive intent under Rule 13d-1(b), with no purpose of changing or influencing control.
  • BIT Capital GmbH is a German investment firm (Investment Firm under section 2 para. 1 WpIG).

Financial Impact

Stake valued at approximately $88.5M based on market cap of $1.5B and 5.9% ownership.

ownership concentration

Risk Factors

  • The filing certifies passive intent; any future activist activity would require a conversion to Schedule 13D.
  • No information on the cost basis or investment thesis is provided.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (24 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0002053305-26-000008
Document: 0002053305-26-000008-index.html0002053305-26-000008
Document: 0002053305-26-000008.txt0002053305-26-000008
5 reports for CMPS
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CMPS, sortable and filterable
TypeNow
Oct 28, 2026
1d ago
SC 13G
NEUTRAL ★ 4/10
$12.28awaiting T+60awaiting T+60$12.19 (−0.73%)
Aug 10, 2026
11w ago
144
NEUTRAL ★ 3/10
$13.18awaiting T+60awaiting T+60$12.19 (−7.51%)
Aug 5, 2026
12w ago
8-K
NEUTRAL ★ 5/10
$13.58 $12.08▼ −11.05%▼ −11.24%$12.19 (−10.24%)
Jul 7, 2026
16w ago
8-K
NEUTRAL ★ 3/10
$12.99 $12.44▼ −4.23%▼ −6.23%$12.19 (−6.16%)
Jun 11, 2026
20w ago
Institutional Cluster
BULLISH ★ 5/10
$11.41 $13.27▲ +16.30%▲ +11.91%$12.19 (+6.84%)
Showing 5 of 5

US Market Status

Market Closed · Opens in 6h 45m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 28, 2026